Metastatic phenotype in CWR22 prostate cancer xenograft following castration

BACKGROUND: CWR22 is a human xenograft model of primary prostate cancer (PCa) that is often utilized to study castration recurrent (CR) PCa. CWR22 recapitulates clinical response to androgen deprivation therapy (ADT), in that tumors regress in response to castration, but can recur after a period of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prostate
Main Authors: Seedhouse, Steven J., Affronti, Hayley C., Karasik, Ellen, Gillard, Bryan M., Azabdaftari, Gissou, Smiraglia, Dominic J., Foster, Barbara A.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4745026/
https://ncbi.nlm.nih.gov/pubmed/26642837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23127
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados